Antiparasitic agents: New drugs on the horizon

Current Opinion in Pharmacology

Volumn 12, Issue 5, 2012, Pages 562-566

  Mäser, Pascal ^a,b   Wittlin, Sergio ^a,b   Rottmann, Matthias ^a,b   Wenzler, Tanja ^a,b   Kaiser, Marcel ^a,b   Brun, Reto ^a,b  

^a SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

^b UNIVERSITY OF BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

2,5 BIS(4 AMIDINOPHENYL)FURAN; ANTIINFECTIVE AGENT; ANTIPARASITIC AGENT; ARTEMISININ; ARTEROLANE; BETA CARBOLINE DERIVATIVE; DB 829; DB 868; DIAMIDINE DERIVATIVE; DRUG METABOLITE; EFLORNITHINE; FEXINIDAZOLE; FEXINIDAZOLE SULFONE; FEXINIDAZOLE SULFOXIDE; NEW DRUG; NIFURTIMOX; NITD 609; OXABOROLE; OZ 439; PAFURAMIDINE; PENTAMIDINE; PEROXIDE; SCYX 6759; SCYX 7158; SPIROINDOLONE; SYNTHETIC PEROXIDE; UNCLASSIFIED DRUG;

AFRICAN TRYPANOSOMIASIS; CARDIOTOXICITY; CENTRAL NERVOUS SYSTEM INFECTION; DRUG ABSORPTION; DRUG HALF LIFE; DRUG METABOLISM; DRUG RESISTANCE; DRUG STRUCTURE; GENOTOXICITY; HUMAN; MALARIA; MALARIA FALCIPARUM; NEPHROTOXICITY; NONHUMAN; PLASMODIUM BERGHEI INFECTION; PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX MALARIA; PNEUMOCYSTOSIS; PRIORITY JOURNAL; PUBLIC-PRIVATE PARTNERSHIP; REVIEW; SINGLE DRUG DOSE; TRYPANOSOMA BRUCEI;

ANIMALS; ANTIPARASITIC AGENTS; HUMANS; MALARIA; PLASMODIUM FALCIPARUM; TRYPANOSOMA BRUCEI BRUCEI; TRYPANOSOMIASIS, AFRICAN;

EID: 84867337640     PISSN: 14714892     EISSN: 14714973     Source Type: Journal    
DOI: 10.1016/j.coph.2012.05.001     Document Type: Review

References (19)

1. M. Delves, D. Plouffe, C. Scheurer, S. Meister, S. Wittlin, E.A. Winzeler, R.E. Sinden, and D. Leroy The activities of current antimalarial drugs on the life cycle stages of Plasmodium: a comparative study with human and rodent parasites PLoS Med 9 2012 e1001169
2. P.L. Alonso, G. Brown, M. Arevalo-Herrera, F. Binka, C. Chitnis, F. Collins, O.K. Doumbo, B. Greenwood, B.F. Hall, and M.M. Levine A research agenda to underpin malaria eradication PLoS Med 8 2011 e1000406
3. S.A. Charman, S. Arbe-Barnes, I.C. Bathurst, R. Brun, M. Campbell, W.N. Charman, F.C. Chiu, J. Chollet, J.C. Craft, and D.J. Creek Synthetic ozonide drug candidate OZ439 offers new hope for a single-dose cure of uncomplicated malaria Proc Natl Acad Sci USA 108 2011 4400 4405
4. M. Rottmann, C. McNamara, B.K. Yeung, M.C. Lee, B. Zou, B. Russell, P. Seitz, D.M. Plouffe, N.V. Dharia, and J. Tan Spiroindolones, a potent compound class for the treatment of malaria Science 329 2010 1175 1180
5. B.K. Yeung, B. Zou, M. Rottmann, S.B. Lakshminarayana, S.H. Ang, S.Y. Leong, J. Tan, J. Wong, S. Keller-Maerki, and C. Fischli Spirotetrahydro beta-carbolines (spiroindolones): a new class of potent and orally efficacious compounds for the treatment of malaria J Med Chem 53 2010 5155 5164
6. G. Priotto, S. Kasparian, W. Mutombo, D. Ngouama, S. Ghorashian, U. Arnold, S. Ghabri, E. Baudin, V. Buard, and S. Kazadi-Kyanza Nifurtimox-eflornithine combination therapy for second-stage African Trypanosoma brucei gambiense trypanosomiasis: a multicentre, randomised, phase III, non-inferiority trial Lancet 374 2009 56 64
7. E. Torreele, B. Bourdin Trunz, D. Tweats, M. Kaiser, R. Brun, G. Mazue, M.A. Bray, and B. Pecoul Fexinidazole - a new oral nitroimidazole drug candidate entering clinical development for the treatment of sleeping sickness PLoS Negl Trop Dis 4 2011 e923
8. W. Raether, and H. Seidenath The activity of fexinidazole (HOE 239) against experimental infections with Trypanosoma cruzi, trichomonads and Entamoeba histolytica Ann Trop Med Parasitol 77 1983 13 26
9. F.W. Jennings, and G.M. Urquhart The use of the 2 substituted 5-nitroimidazole, Fexinidazole (Hoe 239) in the treatment of chronic T. brucei infections in mice Z Parasitenkd 69 1983 577 581
10. M. Kaiser, M.A. Bray, M. Cal, B. Bourdin Trunz, E. Torreele, and R. Brun Antitrypanosomal activity of fexinidazole, a new oral nitroimidazole drug candidate for treatment of sleeping sickness Antimicrob Agents Chemother 55 2011 5602 5608
11. B. Nare, S. Wring, C. Bacchi, B. Beaudet, T. Bowling, R. Brun, D. Chen, C. Ding, Y. Freund, and E. Gaukel Discovery of novel orally bioavailable oxaborole 6-carboxamides that demonstrate cure in a murine model of late stage central nervous system African Trypanosomiasis Antimicrob Agents Chemother 54 2010 4379 4388
12. R.T. Jacobs, B. Nare, S.A. Wring, M.D. Orr, D. Chen, J.M. Sligar, M.X. Jenks, R.A. Noe, T.S. Bowling, and L.T. Mercer SCYX-7158, an orally-active benzoxaborole for the treatment of stage 2 human African trypanosomiasis PLoS Negl Trop Dis 5 2011 e1151
13. R. Brun, J. Blum, F. Chappuis, and C. Burri Human African trypanosomiasis Lancet 375 2010 148 159
14. WHO Human African trypanosomiasis (sleeping sickness) WHO Fact sheet 259 2012
15. T. Wenzler, D.W. Boykin, M.A. Ismail, J.E. Hall, R.R. Tidwell, and R. Brun New treatment option for second-stage African sleeping sickness: in vitro and in vivo efficacy of aza analogs of DB289 Antimicrob Agents Chemother 53 2009 4185 4192
16. R.E. Mdachi, J.K. Thuita, J.M. Kagira, J.M. Ngotho, G.A. Murilla, J.M. Ndung'u, R.R. Tidwell, J.E. Hall, and R. Brun Efficacy of the novel diamidine compound 2,5-Bis(4-amidinophenyl)-furan-bis-O-Methlylamidoxime (Pafuramidine, DB289) against Trypanosoma brucei rhodesiense infection in vervet monkeys after oral administration Antimicrob Agents Chemother 53 2009 953 957
17. C. Burri Chemotherapy against human African trypanosomiasis: is there a road to success? Parasitology 137 2010 1987 1994
18. R. Brun, R. Don, R.T. Jacobs, M.Z. Wang, and M.P. Barrett Development of novel drugs for human African trypanosomiasis Future Microbiol 6 2011 677 691
19. WHO Guidelines for the treatment of malaria WHO Library 2010